PETALING JAYA: With renewed contracts and the potential vaccine deal, Duopharma Biotech Bhd (DBB) is said to be looking attractive, more so as demand for health care services rise amid the Covid-19 pandemic.
The company on Monday even offered a one-for-three bonus issue to reward shareholders after a better financial showing in its first quarter results.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!